Patent Application
20180065908
The present disclosure relates to fields of organic chemistry and organometallic chemistry, and more specifically, to a chain multiyne compound, a preparation method thereof and an application in preparing a fused-ring metallacyclic compound.
Pincer ligands are tridentate ligands that bind tightly to three adjacent coplanar sites of a metal center in a meridional fashion, which can be divided into different type according to the coordinate atoms, such as NCN-, PCP-type pincer ligands. The concept was first proposed in the 1970s. The corresponding metal complexes containing pincer ligands are named as pincer complexes. Pincer complexes are widely used in the field of coordination chemistry, organic synthesis, homogeneous catalysis and material chemistry due to their properties of excellent stability, reactivity and stereoselectivity (Angew. Chem. Int. Ed. 2001, 40, 3750-3781). In recent years, pincer complexes not only play an important role in fields of CC coupling reaction, inert chemical activation, but also have important applications in the field of solar cells, for example, the terpyridine ruthenium complex (black dye) being widely used as optoelectronic materials.
The structure, reactivity, as well as applications studies of pincer complexes have achieved significant progress since the pincer complex first reported in 1976 (J. Chem. Soc. Dalton Trans 1976, 1020-1024). At present, most of the reported pincer complexes contain pincer ligands of NCN-(Coord. Chem. Rev., 2007, 251, 610-641; Coord. Chem. Rev., 2004, 248, 2275-2282), NNN-, PCP type (Chem. Rev., 2003, 103, 1759-1792), PCO- or SCS-type, in which there is at least one hetero coordination atoms. Pincer complexes with carbon exclusively as the bonding atoms (i.e., CCC-type pincer complexes) are rare. In 2013, Xia et al. reported novel fused-ring metallacyclic compounds, metallapentalynes, which can be regarded as a new kind of CCC-type pincer complexes (Nat. Chem. 2013, 5, 698-703). These CCC-type pincer complexes exhibit unique properties, such as aggregation induced emission enhancement, large Stokes shifts and long lifetime, broad absorption from the ultraviolet-visible to the near-infrared region and excellent photoacoustic and photothermal properties, thus posess potential applications in biomedicine and solar energy utilization
Although CCC-type pincer complexes have a good application prospect, how to synthesize these complexes efficiently remains a big challenge due to lack of appropriate CCC pincer ligand or ligand precursor. Therefore, a development and synthesis of the CCC-type pincer ligand or CCC-type pincer ligand precursor are particularly important.
In order to solve a problem of direct synthesizing a fused-ring metallacyclic compound from a pincer ligand, the present invention proposes a chain multiyne compound, a preparation method thereof and the application thereof in synthesizing a fused-ring metallacyclic compound. The chain multiyne compound provided by the invention has multiple functional groups. The preparation method of the chain multiyne compound is simple; a structure of the chain multiyne compound is adjustable, and can be directly used to synthesize the metallacyclic compound.
Applicants of the present invention have found that the chain multiyne compound can be used to synthesize a fused-ring metallacyclic compound directly as CCC-type pincer ligand by quantities of research. Furthermore, the inventors have found that a chain multiyne compound can be obtained by performing a metal exchange reaction of a terminal alkyne with an organometallic reagent in an aprotic solvent and further contacting and reacting the obtained reaction mixture with alkynylaldehyde or alkynylketone. The chain multiyne compound can directly react with a metal complex to obtain the fused-ring metallacyclic compound. Thus, the present invention has been completed.
According to the first aspect of the present invention, this invention discloses a chain multiyne compound, wherein the chain multiyne compound has a structure of Formula I shown below:
wherein X is any one of —O—, —S—, —CR4R5—, —SiR6R7— and —NR8—; the R4, R5, R6, R7, R8 are any one of hydrogen, C1-C20 alkyl, C1-C20 ester, C1-C20 acyl, C3-C20 cycloalkyl, C1-C20 alkyl halide, nitrile group, nitryl, substituted or unsubstituted aryl and
respectively and independently.
The R9 is any one of C1-C8 alkyl and substituted or unsubstituted phenyl.
R1 is any one of nitrile group, substituted or unsubstituted C2-C30 alkynyl, substituted or unsubstituted C4-C30 multiyne, substituted or unsubstituted C3-C30 cumulene, and R1 does not contain a structure unit of —C≡CCH(OH)C≡C—.
R2 and R3 are any one of hydrogen, substituted or unsubstituted aryl, substituted or unsubstituted C1-C8 alkyl, substituted or unsubstituted C1-C8 alkoxy, substituted or unsubstituted C1-C8 alkyithiol, substituted or unsubstituted C3-C8 cycloalkyl and substituted or unsubstituted C2-C8 alkynyl, respectively and independently. R2 and R3 do not contain a structure unit of —C≡CCH(OH)C≡C—.
m and n are integers from 1-6, respectively, and m+n<8.
According to the second aspect of the present invention, this invention discloses a preparation method of the chain multiyne compound, comprising:
step a: performing a metal exchange reaction of a compound of Formula II with an organometallic reagent RM1 and/or RM2Z in an aprotic solvent, and obtaining a reaction mixture;
step b: contacting and reacting the obtained reaction mixture with a compound of Formula III, obtaining a reaction mixture containing a chain multiyne compound with a protection group Y of Formula IV;
step c: taking off the protection group Y from the chain multiyne compound with a protection group Y of Formula IV of the obtained reaction mixture in step b, and obtaining the chain multiyne compound of Formula I:
Wherein, Y is any one of trimethylsilyl (TMS), triethylsilyl (TES) and triisopropylsilyl (TIPS).
R of the organometallic reagent RM1 and/or RM2Z is any one of C1-C8 alkyl, phenyl and —NR10R11. The R10 and R11 are any one of hydrogen, C1-C8 alkyl and trimethylsilyl, respectively and independently. M1 is lithium, or sodium or potassium. M2 is magnesium. Z is chlorine, or bromine or iodine.
Or,
step a: performing a metal exchange reaction of a compound of Formula II with an organometallic reagent RM1 and/or RM2Z in an aprotic solvent, and obtaining a reaction mixture containing;
step b: reacting the obtained reaction mixture with a compound of Formula V, obtaining a mixture containing the chain multiyne compound of Formula I.
Wherein R of the organometallic reagent RM1 and/or RM2Z is any one of C1-C8 alkyl, phenyl and —NR10R11. The R10 and R11 are any one of hydrogen, C1-C8 alkyl and trimethylsilyl, respectively and independently. M1 of the organometallic reagent RM1 is lithium, or sodium or potassium. M2 of the RM2Z is magnesium. Z of the RM2Z is chlorine, or bromine or iodine.
According to the third aspect of the present invention, this invention discloses an application of the chain multiyne compound in synthesizing a fused-ring metallacyclic compound.
The chain multiyne compound disclosed in the present invention has multiple functional groups and the structure of the chain multiyne compound is adjustable and the chain multiyne compound can also be used to synthesize a fused-ring metallacyclic compound efficiently. The preparation method disclosed in the present invention of the chain multiyne compound is simple, which is able to prepare the chain multiyne compound rapidly and efficiently.
Other characteristics and advantages of the present invention are described in details by following detailed embodiments.
Detailed description of the present invention is given below. It should be understood that, the specific embodiments described herein are only used to describe and explain the present invention, and are not intended to limit the present invention.
According to the first aspect of the present invention, this invention discloses a chain multiyne compound, wherein the chain multiyne compound has a structure of Formula I shown below:
wherein X is any one of —O—, —S—, —CR4R5—, —SiR6R7— and —NR8—; the R4, R5, R6, R7, R8 are any one of hydrogen, C1-C20 alkyl, C1-C20 ester group, C1-C20 acyl, C3-C20 cycloalkyl, C1-C20 alkyl halide, nitrile group, nitryl, substituted or unsubstituted aryl and
respectively and independently.
The R9 is any one of C1-C8 alkyl and substituted or unsubstituted phenyl.
The C1-C8 alkyl is any one of methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, neopentyl, sec-pentyl, tert-pentyl, n-hexyl, isohexyl, neo-hexyl, sec-hexyl, tert-hexyl, n-heptyl, isoheptyl, neo-heptyl, sec-heptyl, tert-heptyl, n-octyl, isooctyl, neo-octyl, sec-octyl, tert-octyl.
When the R9 is substituted phenyl, a substituent group of the substituted phenyl can be a halogen or a C1-C8 alkyl. The halogen is any one of F, Cl, Br, and I. The C1-C8 alkyl is the same as just mentioned above.
Wherein, the C1-C20 alkyl is any one of methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, neopentyl, sec-pentyl, tert-pentyl, n-hexyl, isohexyl, neo-hexyl, sec-hexyl, tert-hexyl, n-heptyl, isoheptyl, neo-heptyl, sec-heptyl, tert-heptyl, n-octyl, isooctyl, neo-octyl, sec-octyl, tert-octyl, n-dodecyl, n-cetyl, n-octadecyl, n-eicosyl,
The C1-C20 ester refers to a group which has a total carbon atom number of 1-20 and an ester
group, and with one hydrogen absent. For example, the C1-C20 ester can be any one of
The C1-C20 acyl is any one of
The C3-C20 cycloalkyl is any one of cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclodedecyl, cyclooctadecyl, cycloeicosyl.
The C1-C20 alkyl halide is a substituted C1-C20 alkyl in which at least one hydrogen atom is substituted by at least any one of F, Cl, Br, and I.
The aryl group is any one of phenyl, naphthyl, anthryl, phenanthryl, pyrenyl, thienyl, furyl, pyridyl, pyrryl.
A substituent group of the substituted aryl is any one of C1-C8 alkyl, C1-C8 alkoxy, C1-C8 alkylthiol, C1-C8 acyl, C1-C8 acylamino, C1-C8 ester, C1-C8 carboxyl, C1-C8 amido, C3-C8 cycloalkyl, halogen, nitryl, and nitrile.
Wherein, the C1-C8 alkyl is the same as mentioned above.
The C1-C8 alkoxy is any one of methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, sec-butoxy, tert-butoxy, n-pentyloxy, isopentyloxy, neo-pentyloxy, sec-pentyloxy, tert-pentyloxy, n-hexyloxy, isohexyloxy, neo-hexyloxy, sec-hexyloxy, tert-hexyloxy, n-heptyloxy, isoheptyloxy, neo-heptyloxy sec-heptyloxy, tert-heptyloxy, n-octyloxy, isooctyloxy, neo-octyloxy, sec-octyloxy and tert-octyloxy.
The C1-C8 alkyithiol is any one of methylthio, ethylthio, n-propylthio, isopropylthio, n-butylthio, isobutylthio, sec-butylthio, tert-butylthio, n-pentylthio, isopentylthio, neo-pentylthio, sec-pentylthio, tert-pentylthio, n-hexylthio, isohexylthio, neo-hexylthio, sec-hexylthio, tert-hexylthio, n-heptylthio, isoheptylthio, neo-heptylthio, sec-heptylthio, tert-heptylthio, n-octylthio, isooctylthio, neo-octylthio, sec-octylthio and tert-octylthio.
The C1-C8 acyl is any one of
The C1-C8 acylamino is a group with one hydrogen absent, which has a total carbon atom number of 1-8 and acylamino
For example, the C1-C8 acylamino can be any one of
The C1-C8 ester is a group with one hydrogen absent, which has a total carbon atom number of 1-8 and ester
the C1-C8 ester is any one of
The C1-C8 carboxyl is a group with one hydrogen absent, which has a total carbon atom number of 1-8 and carboxyl
For example, the C1-C8 carboxyl can be any one of
The C1-C8 amido is any one of methylamino, ethylamino, propylamino, butylamino, pentylamino, hexylamino, heptylamino, octylamino, dimethylamino, diethylamino, dipropylamino and dibutylamino.
The C3-C8 cycloalkyl is any one of cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl and cyclooctyl.
The halogen is any one of F, Cl, Br and I.
The R1 is any one of nitrile group, substituted or unsubstituted C2-C30 alkynyl, substituted or unsubstituted C4-C30 multiyne, substituted or unsubstituted C3-C30 cumulene, and R1 does not contain a structure unit of —C≡CCH(OH)C≡C—.
The substituted or unsubstituted C2-C30 alkynyl is any one of acetenyl,
The C4-C30 multiyne is any one of
The C3-C30 cumulene is a residual alkene which contains more than one couple of adjacent carbon-carbon double bond (cumulative double bond). The C3-C30 cumulene is any one of
Wherein, a substituent group of the substituted or unsubstituted C2-C30 alkynyl, the substituted or unsubstituted C4-C30 multiyne, and the substituted or unsubstituted C3-C30 cumulene is any one of substituted or unsubstituted aryl, C1-C8 alkyl, C1-C8 alkoxy, C1-C8 alkylthiol, C3-C8 cycloalkyl and C1-C8 halogen alkyl.
The substituted or unsubstituted acyl, C1-C8 alkyl, C1-C8 alkoxy, C1-C8 alkylthiol, C3-C8 cycloalkyl is the same as mentioned above.
The C1-C8 alkyl halide is a substituted C1-C8 alkyl of which at least one hydrogen atom is substituted by at least any one of F, Cl, Br, and I.
It should be noted that the number of carbon atoms in the substituted C2-C30 alkynyl groups described herein is 2-30, excluding a number of carbon atoms in the substituent group and only including the number of carbon atoms in the alkynyl group. Similarly, any numbers of carbon atoms mentioned in the present invention refer to the number of number of carbon atoms in the group, excluding the number of carbon atoms in the substituent group.
The R2 and R3 are any one of hydrogen, substituted or unsubstituted aryl, substituted or unsubstituted C1-C8 alkyl, substituted or unsubstituted C1-C8 alkoxy, substituted or unsubstituted C1-C8 alkylthiol, substituted or unsubstituted C3-C8 cycloalkyl and substituted or unsubstituted C2-C8 alkynyl, respectively and independently. R2 and R3 do not contain a structure unit of —C≡CCH(OH)C≡C—.
Wherein, a substituted group of the substituted or unsubstituted C1-C8 alkyl, the substituted or unsubstituted C1-C8 alkoxy, the substituted or unsubstituted C1-C8 alkylthiol, the substituted or unsubstituted C3-C8 cycloalkyl and the substituted or unsubstituted C2-C8 alkynyl, is aryl or substituted aryl. The aryl or the substituted aryl is same as mentioned above.
The substituted or unsubstituted aryl, C1-C8 alkyl, C1-C8 alkoxy, C1-C8 alkylthiol, C3-C8 cycloalkyl are the same as mentioned above.
The C2-C8 alkynyl is any one of ethynyl, propynyl, 1-butynyl, 3-methyl-1-butynyl, 1-pentynyl, 3-methyl-1-pentynyl, 4-methyl-1-pentynyl, 1-hexynyl, 1-heptynyl, 1-octynyl and phenylethynyl.
m and n are integers from 1-6, respectively, and m+n<8. For example, under a condition of m+n<8, m and n are 1, 2, 3, 4, 5, or 6, independently and respectively. Specifically, m=1 and n=1, 2, 3, 4, 5, or 6; or m=2 and n=1, 2, 3, 4 and 5; or m=3 and n=1, 2, 3 and 4; or m=4 and n=1, 2, and 3; or m=5, n=1 or 2; or m=6, n=1.
Preferably, the X is any one of —O—, —S—, —CH2—, —C(CH3)2—, —CHCH3—, —C(COOMe)2-, —C(COOEt)2-, —C(COCH3)(COOMe)-, —C(Cy)(COOMe)-, —C(CH2CH2Br)2—, —C(CN)2—, —C(NO2)2—, —SiH2—, —SiMe2-, —SiPh2-, —NH—,
Preferably, the R1 is any one of nitrile, acetenyl,
Preferably, R2 or R3 respectively and independently is any one of hydrogen, methyl, ethyl, n-propyl, isoproyl, methoxy, ethyoxyl, n-propoxy, isopropoxy, methylthio, ethylthio, cyclopropyl, cyclohexyl,
ethynyl, propynyl,
benzyl and phenethyl.
According to the present invention, preferably, the chain multiyne compound is any one of
According to the second aspect of the present invention, this invention discloses a preparation method of the chain multiyne compound. When the substituent group of the chain multiyne compound R3 is hydrogen, the preparation method 1 is adopted, comprising:
step a: performing a metal exchange reaction of a compound of Formula II with an organometallic reagent RM1 and/or RM2Z in an aprotic solvent, and obtaining a reaction mixture;
step b: contacting and reacting the obtained reaction mixture with a compound of Formula III, obtaining a reaction mixture containing a chain multiyne compound with a protection group Y of Formula IV;
step c: taking off the protection group Y from the chain multiyne compound with a protection group Y of Formula IV of the obtained reaction mixture in step b, and obtaining the chain multiyne compound of Formula I.
wherein, Y is a protection group to protect alkynyl, Y is any one of trimethylsilyl (TMS), triethylsilyl (TES) and triisopropylsilyl (TIPS). X, R1, m and n are respectively all the same as mentioned above.
The R of the organometallic reagent RM1 and/or RM2Z is any one of C1-C8 alkyl, phenyl and —NR10R11. The R10 or R11 of —NR10R11 are any one of hydrogen, C1-C8 alkyl and trimethylsilyl respectively and independently. The C1-C8 alkyl is the same as mentioned above. M1 is lithium, or sodium or potassium. M2 is magnesium, Z is chlorine, or bromine or iodine. Preferably, the RM1 is at least any one of methyl lithium, ethyl lithium, n-butyl lithium, t-butyl lithium, phenyllithium, lithium diisopropylamide and lithium bis (trimethylsilyl) amide. Preferably, the RM2Z is at least any one of methylmagnesium bromide, ethylmagnesium bromide, methylmagnesium chloride and ethylmagnesium chloride.
According to the present invention, the protection group Y is deprotected from the obtained chain multiyne compound with a protection group Y of Formula IV by the deprotection agent, wherein the deprotection agent is at least one of K2CO3, Na2CO3, Cs2CO3, KF, (n-Bu)4NF (tetrabutylammonium fluoride), (Et)4NF (tetraethylammonium fluoride), (Me)4NF (tetramethylammonium fluoride) and (n-Pr)4NF (tetrapropylammonium fluoride).
According to the present invention, before the protection group Y is taken off from the obtained chain multiyne compound with a protection group Y of Formula IV by the deprotection agent, quenching and purifying processes are performed on the reaction mixture of step a which contains the chain multiyne compound with a protection group Y of Formula IV. Wherein, saturated ammonium chloride and/or water is used as a quenching agent in the quenching process. The purification process comprises extracting the chain multiyne compound with a protection group Y of Formula I by an organic solvent, drying, filtrating, concentrating, chromatographic separating the extracted organic phase, and obtaining the chain multiyne compound of Formula I. Wherein the organic solvent is at least one of diethyl ether, n-hexane, methylbenzene, 1,2-dimethoxyethane, 1,4-dioxane, dichloromethane and trichloromethaneis. The drying process on the organic phase comprises using anhydrous magnesium sulfate and/or anhydrous sodium sulfate. The chromatographic separating process on the organic phase comprises using silica gel column chromatography and/or neutral alumina.
According to the present invention, preferably, after the protection group Y is taken off from the obtained chain multiyne compound with a protection group Y of Formula IV by the deprotection agent, quenching and purifying processes are performed on the obtained mixture which contains the chain multiyne compound with a protection group Y of Formula I, the quenching and purifying processes are the same as mentioned above.
According to the second aspect of the present invention, when the R3 of the chain multiyne compound of Formula I is any one of substituted or unsubstituted aryl, substituted or unsubstituted C1-C8 alkyl, substituted or unsubstituted C1-C8 alkoxy, substituted or unsubstituted C1-C8 alkyl sulphanyl, substituted or unsubstituted C3-C8 cycloalkyl and substituted or unsubstituted C2-C8 alkynyl, the preparation method 2 is adopted, comprising:
step a: performing a metal exchange reaction of a compound of Formula II with an organometallic reagent RM1 and/or RM2Z in an aprotic solvent, and obtaining a reaction mixture containing;
step b: reacting the obtained reaction mixture with a compound of Formula V, obtaining a mixture containing the chain multiyne compound of Formula I.
Wherein, the organometallic reagent RM1 and/or RM2Z is the same as mentioned above. X, R1, R2, m and n are the same as mentioned above, respectively.
According to the second aspect of the present invention, there is no special quantity ratio of the compound of the Formula II to the sum of the organometallic agent RM1 and/or RM2Z. Preferably, the molar ratio of the compound of the Formula II to the sum of the organometallic agent RM1 and/or RM2Z is 1:(0.5-1), and preferably 1:(0.9-1). When both RM1 and RM2Z are comprised, there is no special quantity ratio of the compound of the Formula II to the sum of the organometallic agent RM1 and/or RM2Z. RM1 and RM2Z can be mixed and used with any molar ratio.
According to the second aspect of the present invention, there is no special limitation on the aprotic solvent. Preferably, the aprotic solvent is at least one of benzene, methylbenzene, n-haxane, ethylether, 1,2-dimethoxyethane, tetrahydrofuran, 1,4-dioxane, petroleum ether and gasoline.
According to the second aspect of the present invention, the metal exchange reaction is performed of the compound of the Formula II and the organometallic agent RM1 and/or RM2Z under protection of an inert gas. The inert gas is any gas that does not react with catalyst, raw material or product and does not have any negative effect on the reaction. The inert gas is at least one of nitrogen gas, helium gas, argon gas and neon gas. The condition of contacting the compound of the Formula II with the organometallic agent RM1 and/or RM2Z in the aprotic solvent, comprises a temperature at −100-30° C., preferably at −78-0° C., with time of contact for 0.5-10 hours, preferably for 1-3 hours.
According to the second aspect of the present invention, the condition of contacting the obtained reaction mixture by contacting the compound of the Formula II with the organometallic agent RM1 and/or RM2Z in an aprotic solvent with the compound of the Formula V, comprises a temperature at −100-30° C., preferably at −78-0° C., with time of contact for 0.5-10 hours, preferably for 1-5 hours.
According to the third aspect of the present invention, this invention discloses the application of the chain multiyne compound in synthesizing a fused-ring metallacyclic compound.
According to the present invention, the application of the chain multiyne compound in synthesizing a fused-ring metallacyclic compound comprises obtaining the fused-ring metallacyclic compound by reacting the chain multiyne compound with the metal complex.
According to the present invention, the metal complex is DEaLb.
Wherein, the D is any one of Fe, Co, Ni, Ru, Mn, Re, Cr, Mo, W, V, Nb, Ta, Ti, Zr, Hf, Rh, Pd, Ir, Pt and Os.
The E is any one of H, F, Cl, Br, I, SCN and CN.
The L is any one of a phosphine ligand, a CO ligand, a pyridine ligand, a N-heterocyclic carbene ligand, a nitrile ligand and an isocyanoid ligand.
Preferably, the L is any one of trimethylphosphine, triethylphosphine, tripropylphosphine, triisopropylphosphine, tritertbutylphosphine, tricyclohexylphosphine, triphenylphosphine, methylpyridine, ethylpyridine, 1, 4-bipyridine, 1,2-bis(4-pyridyl)ethylene, vinylpyridine, pyridine-3-boronic acid, aminopyridine, cyanopyridine, pyridinethiol, ethynylpyridine, dimethylaminopyridine, ethylene pyridine, phenylpyridine, 1,2-bis(4-pyridyl)ethane, imidazole N-heterocyclic carbene, imidazoline N-heterocyclic carbene, thiazole N-heterocyclic carbene, triazole N-heterocyclic carbene, acetonitrile, propionitrile, benzonitrile, cyclohexylisocyanide, tert-butylisocyanide and phenylsocyanide.
The a and b are integers from 0-6, respectively; when a≧2, E is different or is the same and when b≧2, L is different or is the same.
Preferably, the metal complex is any one of OsCl2(PPh3)3, RuCl2(PPh3)3, RhCl(PPh3)3 and IrHCl2(PPh3)3.
The present invention is hereinafter described in details by specific embodiments.
The present embodiment is to prepare the chain multiyne compound disclosed in the present invention.
Wherein, TMS represents trimethylsilyl, EtMgBr is ethylmagnesium bromide (purchased from J & K Technology Co., Ltd., and a trademark number is 248474),
is 3-trimethylsilylpropynal (purchased from J & K Technology Co., Ltd., and a trademark number is 2975-46-4), (n-Bu)4NF is tetrabutylammonium fluoride (purchased from J & K Technology Co., Ltd., and a trademark number is A10588).
Step 1. the preparation of the compound 1 (see above)
1,6-heptadiyne (5.0 mL, 4.02 g, 43.63 mmol, purchased from Aladdin Reagent (Shanghai) Co., Ltd., and a trademark number is H102744-25 mL) was dissolved into 100 mL tetrahydrofuran under an atmosphere of N2 and magnetic stirring.
The solution was cooled to 0° C., a solution of ethylmagnesium bromide (1.0 M tetrahydrofuran solution, 43.6 mL, and containing ethylmagnesium bromide 43.60 mmol) was added gradually within 1 h.
The solution reacted for another 1 h at room temperature and then cooled to 0° C.
Trimethylsilylpropynal (7.30 mL, 43.60 mmol) was added rapidly and reacted for 1 h.
After reaction, the solution was quenched with saturated ammonium chloride, and the solution was extracted with diethyl ether.
The organic phase was merged and the organic phase was dried with anhydrous magnesium sulfate.
The organic solution was filtrated, concentrated to dryness. The residue was chromatographed with silica gel (eluent:n-hexane:ethyl acetate=6:1(v/v)) to obtain 5.71 g compound 1 as colorless oily liquid. A yield is 60%. (The yield of compound 1 is calculated as a molar amount of the compound 1 divided by a molar amount of 1,6-heptanedyne×100%.)
NMR data and high resolution mass spectrometry data of the compound 1 are as follows.
1H NMR δ=5.04 (t, J=1.80 Hz, 1H), 2.69 (br, 1H), 2.31 (td, J=6.99 Hz, J=1.80 Hz, 2H), 2.25 (td, J=6.99 Hz, J=2.60 Hz, 2H), 1.93 (t, J=2.60 Hz, 1H), 1.69 (m, 2H), 0.14 (s, 9H); 13C NMR δ=102.71, 88.81, 84.24, 83.45, 78.31, 69.12, 52.59, 27.25, 17.82, 17.56, −0.26. HRMS-ESI (m/z) calculated value C13H18OSiNa [M+Na]+ 241.1019, measured value 241.1025.
Step 2. the preparation of the compound 2 (see above).
The compound 1 (5.0 g, 22.90 mmol) was dissolved into 120 mL tetrahydrofuran.
The solution was cooled to 0° C. A solution of tetrabutylammonium fluoride (1.0 M tetrahydrofuran solution, 27.48 mL, containing tetrabutylammonium fluoride 27.48 mmol) was slowly added.
The reaction was stopped until the raw materials disappeared (about 30 min).
The reaction solution was quenched with saturated ammonium chloride, and then extracted with diethyl ether.
The organic phase was merged and the organic phase was dried with anhydrous magnesium sulfate.
The organic solution was filtrated, concentrated to dryness. The residue was chromatographed with silica gel (eluent:n-hexane/ethyl acetate with a volume ratio of 4/1) to obtain 2.85 g compound 2 as colorless oily liquid. Yield is 85%. (The yield of compound 2 is calculated as a molar amount of the compound 2 divided by a molar amount of the compound 1×100%.)
NMR data and high resolution mass spectrometry data of the compound 2 are as follows.
1H NMR δ=5.08 (m, 1H), 2.69 (br, 1H), 2.53 (t, J=2.20 Hz, 1H), 2.34 (td, J=7.00 Hz, J=1.85 Hz, 2H), 2.25 (td, J=7.00 Hz, J=2.57 Hz, 2H), 1.95 (t, J=2.57 Hz, 1H), 1.71 (m, 2H); 13C NMR δ=84.65, 83.49, 81.52, 77.91, 72.39, 69.22, 52.06, 27.18, 17.77, 17.62. HRMS-ESI (m/z) calculated value C10H10OSiNa [M+Na]+ 169.0624, measured value 169.0651.
The present embodiment is to prepare the chain multiyne compound disclosed in the present invention.
Wherein, n-BuLi represents n-butyllithium (purchased from J & K Technology Co., Ltd., and a trademark number is 913796).
Step 1. the preparation of the compound 3 (see above)
2,2-dimethyl dipropargylmalonate (5.0 g, 24.0 mmol, synthesized according to literature J. Am. Chem. Soc. 2013, 135, 8133.) was dissolved into 200 mL tetrahydrofuran under an atmosphere of N2 and magnetic stirring.
The solution was cooled to −78° C., n-butyllithium (2.2 M tetrahydrofuran solution, 10.90 mL, containing n-butyllithium 24.0 mmol) was added gradually for 1 h.
The solution reacted at −78° C. for 15 mins.
Trimethylsilylpropynal (3.52 mL, 24.0 mmol) was added rapidly and reacted for 2 h.
After reaction, the solution was quenched with saturated ammonium chloride, and the solution was extracted with diethyl ether.
The organic phase was merged and the organic phase was dried with anhydrous magnesium sulfate.
The organic solution was filtrated, concentrated to dryness. The residue was chromatographed with silica gel (eluent:n-hexane:ethyl acetate=5:1 (v/v)) to obtain 4.82 g compound 3 as light yellow oily liquid. The yield is 60%. (The yield of compound 3 is calculated as a molar amount of the compound 3 divided by a molar amount of 2,2-dimethyl dipropargylmalonate×100%.)
NMR data and high resolution mass spectrometry data of the compound 3 are as follows.
1H NMR δ=5.03 (s, 1H), 3.76 (s, 6H), 3.03 (d, J=2.00 Hz, 2H), 2.97 (d, J=2.64 Hz, 2H), 2.37 (br, 1H), 2.03 (t, J=2.60 Hz, 1H), 0.19 (s, 9H); 13C NMR δ=169.05, 102.11, 88.97, 81.08, 79.06, 78.28, 71.88, 56.59, 53.14, 52.30, 22.93, 22.77, −0.41; HRMS-ESI (m/z) calculated value C17H22O5SiNa [M+Na]+357.1129, measured value 357.1130.
Step 2. the preparation of the compound 4 (see above).
The compound 3 (4.82 g, 14.4 mmol) was dissolved into 150 mL tetrahydrofuran.
The solution was cooled to −30° C., a solution of tetrabutylammonium fluoride (1.0 M tetrahydrofuran solution, 21.6 mL, containing tetrabutylammonium fluoride 21.6 mmol) was added slowly.
The solution reacted until the raw materials disappear (about 20 min).
The reacted solution was quenched with saturated ammonium chloride, and the solution was extracted with diethyl ether. The organic phase was dried with anhydrous magnesium sulfate.
The organic solution was filtrated, concentrated to dryness. The residue was chromatographed with silica gel (eluent:n-hexane:ethyl acetate=3:1(v/v)) to obtain 3.21 g compound 4 as light yellow oily liquid. Yield is 85%. (The yield of compound 4 is calculated as a molar amount of the compound 4 divided by a molar amount of the compound 4×100%.)
NMR data and high resolution mass spectrometry data of the compound 4 are as follows.
1H NMR δ=5.05 (ddt, J=7.51 Hz, J=2.25 Hz, J=2.11 Hz, 1H), 3.76 (s, 1H), 3.02 (d, J=2.11 Hz, 2H), 2.95 (d, J=2.72 Hz, 2H), 2.81 (d, J=7.51 Hz, 1H), 2.53 (d, J=2.25 Hz, 1H), 2.03 (t, J=2.68 Hz, 1H); 13C NMR δ=169.11, 80.99, 80.78, 79.03, 78.19, 72.44, 72.10, 56.48, 53.25, 51.54, 22.84, 22.75; HRMS-ESI (m/z) calculated value C14H14O5Na [M+Na]+ 285.0733, measured value 285.0734.
The present embodiment is to prepare the chain multiyne compound disclosed in the present invention.
Step 1. the preparation method of compound 5 is the same as that of compound 1, except the following characteristics:
the 1,6-heptadiyne used in embodiment 1 is replaced by dipropargyl ether (purchased from Alfa Aesar (China) Chemical Co., Ltd., and a trademark number is MFCD00048108) with an equal molar amount.
Yield of compound 5 is 75%. The yield of compound 5 is calculated as a molar amount of the compound 5 divided by a molar amount of dipropargyl ether×100%.
NMR data and high resolution mass spectrometry data of the compound 5 are as follows.
1H NMR δ=5.14 (t, J=1.67 Hz, 1H), 4.31 (d, J=1.67 Hz, 1H), 4.24 (b, J=2.37 Hz, 2H), 2.47 (br, 1H), 2.46 (t, J=2.37 Hz, 1H), 0.17 (s, 9H); 13C NMR δ=101.60, 89.95, 84.19, 79.74, 78.85, 75.40, 56.81, 56.75, 52.59, −0.22; HRMS-ESI (m/z) calculated value C12H16O2SiNa [M+Na]+ 243.0812, measured value 248.0805.
Step 2. the preparation method of compound 6 is the same as that of compound 2, except the following characteristics:
the compound 1 in step 2 of embodiment 1 is replaced by the compound 5 in step 1 of the present embodiment.
The yield of the compound 6 is 87%. (The yield of compound 6 is calculated as a molar amount of the compound 6 divided by a molar amount of the compound 5×100%.)
NMR data and high resolution mass spectrometry data of the compound 6 are as follows.
1H NMR δ=5.16 (s, 1H), 2.69 (br, 1H), 4.31 (d, J=1.52 Hz, 1H), 4.25 (d, J=2.25 Hz, 2H), 2.80 (br, 2H), 2.57 (d, J=2.25 Hz, 1H), 2.47 (t, J=2.25 Hz, 1H); 13C NMR δ=83.81, 80.69, 80.09, 78.82, 75.47, 73.13, 56.87, 56.76, 52.05; HRMS-ESI (m/z) calculated value C9H8O2Na [M+Na]+ 171.0417, measured value 171.0411.
The present embodiment is to prepare the chain multiyne compound disclosed in the present invention.
Step 1. the preparation method of compound 7 is the same as that of compound 1, except the following characteristics:
the 1,6-heptadiyne used in embodiment 1 is replaced by N,N-Dipropargyl-p-toluenesulfonamide (synthesized according to literature J. Am. Chem. Soc. 2000, 122, 11529.) with an equal molar amount.
Yield of compound 7 is 60%. The yield of compound 7 is calculated as a molar amount of the compound 7 divided by a molar amount of N,N-Dipropargyl-p-toluenesulfonamide×100%.
NMR data and high resolution mass spectrometry data of the compound 7 are as follows.
1H NMR δ=7.64 (d, J=12.34 Hz, 2H), 7.35 (d, J=12.34 Hz, 2H), 5.16 (t, J=1.64 Hz, 1H), 3.95 (d, J=1.64 Hz, 2H), 3.87 (d, J=2.37 Hz, 2H), 2.65 (br, 1H), 2.49 (t, J=2.37 Hz, 1H), 2.34 (s, 3H), 0.13 (s, 9H); 13C NMR δ=137.50, 136.79, 129.87, 128.37, 102.50, 87.85, 84.11, 80.74, 78.64, 74.80, 52.64, 34.83, 34.55, 21.56, −0.32; HRMS-ESI (m/z) calculated value C19H23NSO3SiNa [M+Na]+ 396.1060, measured value 396.1058.
Step 2. the preparation method of compound 8 is the same as that of compound 2, except the following characteristics.
The compound 1 in step 2 of embodiment 1 is replaced by the compound 7 in step 1 of the present embodiment.
The yield of the compound 8 is 81%. The yield of compound 8 is calculated as a molar amount of the compound 8 divided by a molar amount of the compound 7×100%.
NMR data and high resolution mass spectrometry data of the compound 8 are as follows.
1H NMR δ=7.63 (d, J=12.37 Hz, 2H), 7.32 (d, J=12.37 Hz, 2H), 5.19 (dt, J=2.35 Hz, J=1.64 Hz, 1H), 3.93 (d, J=1.64 Hz, 2H), 3.85 (d, J=2.36 Hz, 2H), 2.55 (br, 1H), 2.52 (d, J=2.35 Hz, 1H), 2.47 (t, J=2.36 Hz, 1H), 2.33 (s, 3H); 13C NMR δ=137.48, 136.72, 129.77, 128.27, 87.835, 84.01, 80.33, 78.54, 74.58, 72.76, 52.53, 34.92, 34.48, 21.57; HRMS-ESI (m/z) calculated value C16H15NSO3Na [M+Na]+ 324.0665, measured value 324.0661.
The present embodiment is to prepare the chain multiyne compound disclosed in the present invention.
Step 1. the preparation method of compound 9 is the same as that of compound 1, except:
the 1,6-heptadiyne used in embodiment 1 is replaced by 1,7-octadiyne (purchased from Alfa Aesar (China) Chemical Co., Ltd., and a trademark number is MFCD0000880) with an equal molar amount.
The yield of compound 9 is 45%. The yield of compound 9 is calculated as a molar amount of the compound 9 divided by a molar amount of 1,7-octadiyne×100%.
NMR data and high resolution mass spectrometry data of the compound 9 are as follows.
1H NMR δ=5.07 (t, J=1.97 Hz, 1H), 2.55 (br, 1H), 2.25 (td, J=7.00 Hz, J=1.85 Hz, 2H), 2.20 (td, J=7.00 Hz, J=2.80 Hz, 2H), 1.95 (t, J=2.51 Hz, 1H), 1.63 (m, 4H), 0.17 (s, 9H); 13C NMR δ=102.62, 88.75, 84.91, 84.06, 77.82, 68.67, 52.55, 27.40, 27.13, 18.22, 17.09, −0.33; HRMS-ESI (m/z) calculated value C14H20OSiNa [M+Na]+ 255.1176, measured value 255.1152.
Step 2. the preparation method of compound 10 is the same as that of compound 2, except the following characteristics:
the compound 1 in step 2 of embodiment 1 is replaced by the compound 9 in step 1 of the present embodiment.
The yield of the compound 10 is 78%. The yield of compound 10 is calculated as a molar amount of the compound 10 divided by a molar amount of the compound 9×100%.
NMR data and high resolution mass spectrometry data of the compound 10 are as follows.
1H NMR δ=5.08 (d, J=2.20 Hz, 1H), 2.90 (br, 1H), 2.54 (d, J=2.25 Hz, 1H), 2.23 (td, J=6.57 Hz, J=1.97 Hz, 2H), 2.19 (td, J=6.65 Hz, J=2.54 Hz, 2H, 2H), 1.95 (d, J=2.59 Hz, 1H), 1.60 (m, 4H); 13C NMR δ=85.21, 84.14, 76.83, 72.28, 68.77, 51.91, 27.38, 27.10, 18.15, 17.88; HRMS-ESI (m/z) calculated value C11H12ONa [M+Na]+ 183.0780, measured value 183.0785.
The present embodiment is to prepare the chain multiyne compound disclosed in the present invention.
Step 1. the preparation method of compound 11 is the same as that of compound 3, except the following characteristics:
the 2,2-dimethyl dipropargylmalonate used in embodiment 2 is replaced by 5-cyano-1-pentyne (purchased from J & K Technology Co., Ltd., and a trademark number is 009109) with an equal molar amount.
The compound 11 is light yellow oily liquid. The yield of compound 11 is 81%. The yield of compound 11 is calculated as a molar amount of the compound 11 divided by a molar amount of 5-cyano-1-pentyne×100%.
NMR data and high resolution mass spectrometry data of the compound 11 are as follows.
1H NMR δ=5.07 (t, J=1.85 Hz, 1H), 2.54 (br, 1H), 2.48 (t, J=7.08 Hz, 2H), 2.41 (td, J=6.74 Hz, J=1.85 Hz, 2H), 1.87 (tt, J=7.08 Hz, J=6.74 Hz, 2H), 0.17 (s, 9H); 13C NMR δ=119.23, 102.22, 89.39, 82.51, 79.59, 52.60, 24.29, 17.99, 16.23, −0.22. HRMS-ESI (m/z) calculated value C12H17NOSiNa [M+Na]+ 242.0972, measured value 242.0968.
Step 2. the preparation method of compound 12 is the same as that of compound 4, except the following characteristics:
the compound 3 in step 2 of embodiment 2 is replaced by the compound 11 in step 1 of the present embodiment.
The compound 12 is light yellow oily liquid. Yield of the compound 12 is 87%. The yield of compound 12 is calculated as a molar amount of the compound 12 divided by a molar amount of the compound 11×100%.
NMR data and high resolution mass spectrometry data of the compound 12 are as follows.
1H NMR δ=5.09 (dd, J=2.00 Hz, J=1.70 Hz, 1H), 2.65 (br, 1H), 2.56 (d, J=2.00 Hz, 1H), 2.49 (t, J=7.13 Hz, 2H), 2.42 (td, J=6.73 Hz, J=1.70 Hz, 2H), 1.88 (tt, J=7.13 Hz, J=6.73 Hz, 1H); 13C NMR δ=119.28, 82.79, 81.24, 79.25, 72.63, 52.01, 24.21, 17.94, 16.29. HRMS-ESI (m/z) calculated value C9H9NONa [M+Na]+ 170.0576, measured value 170.0583.
The present embodiment is to prepare the chain multiyne compound disclosed in the present invention.
Step 1. the preparation method of compound 13 is the same as that of compound 3, except the following characteristics:
the 2,2-dimethyl dipropargylmalonate used in embodiment 2 is replaced by 4-propargyloxy-1,2-butadiene (synthesized according to literature Eur J. Org. Chem. 2013, 15, 3041, and PCT Int. Appl., 2011050016) with an equal molar amount.
The compound 13 is light yellow oily liquid. The yield of compound 13 is 55%. The yield of compound 13 is calculated as a molar amount of the compound 13 divided by a molar amount of 4-propargyloxy-1,2-butadiene×100%.
NMR data and high resolution mass spectrometry data of the compound 13 are as follows.
1H NMR δ=5.20 (tt, J=6.69 Hz, J=6.69 Hz, 1H), 5.15 (t, J=1.84, 1H), 4.78 (dt, J=6.69 Hz, J=2.34 Hz, 2H), 4.23 (d, J=1.84 Hz, 2H), 4.12 (dt, J=6.69 Hz, J=2.34 Hz, 2H), 2.68 (br, 1H), 0.11 (s, 9H); 13C NMR δ=209.36, 101.23, 86.51, 83.24, 80.67, 80.12, 75.67, 72.53, 67.32, 56.91, 52.35; HRMS-ESI (m/z) calculated value C13H18O2SiNa [M+Na]+ 257.0968, measured value 257.0986.
Step 2. the preparation method of compound 14 is the same as that of compound 4, except the following characteristics:
the compound 3 in step 2 of embodiment 2 is replaced by the compound 13 in step 1 of the present embodiment.
The compound 14 is light yellow oily liquid. The yield of the compound 14 is 87%. The yield of compound 14 is calculated as a molar amount of the compound 14 divided by a molar amount of the compound 13×100%.
NMR data and high resolution mass spectrometry data of the compound 14 are as follows.
1H NMR δ=5.22 (tt, J=6.71 Hz, J=6.71 Hz, 1H), 5.16 (dt, J=1.84 Hz, J=1.84, 1H), 4.81 (dt, J=6.71 Hz, J=2.35 Hz, 2H), 4.23 (d, J=1.84 Hz, 2H), 4.09 (dt, J=6.71 Hz, J=2.35 Hz, 2H), 2.71 (br, 1H), 2.57 (d, J=1.84 Hz, 1H); 13C NMR δ=209.57, 86.81, 83.45, 80.77, 80.13, 76.01, 72.81, 67.46, 56.81, 51.50; HRMS-ESI (m/z) calculated value C10H10O2Na [M+Na]+ 185.0573, measured value 185.0574.
The present embodiment is to prepare the chain multiyne compound disclosed in the present invention.
Step 1. the preparation method of compound 15 is the same as that of compound 3, except the following characteristics:
the 2,2-dimethyl dipropargylmalonate used in embodiment 2 is replaced by 2-propargyl-2-(5-phenyl-2,4-pentadiynyl) dimethyl malonate (synthesized according to literature J. Am. Chem. Soc. 2008, 130, 14713.) with an equal molar amount.
The compound 15 is light yellow oily liquid. Yield of compound 15 is 45%. The yield of compound 15 is calculated as a molar amount of the compound 15 divided by a molar amount of 2-propargyl-2-(5-phenyl-2,4-pentadiynyl) dimethyl malonate×100%.
NMR data and high resolution mass spectrometry data of the compound 15 are as follows.
1H NMR δ=7.30-7.48 (m, 5H), 5.04 (dt, J==7.61 Hz, J=2.02 Hz, 1H), 3.79 (s, 6H), 3.16 (s, 2H), 3.07 (d, J=2.02 Hz, 2H), 2.35 (d, J=7.61 Hz, 1H), 0.19 (s, 9H); 13C NMR δ=168.86, 132.57, 129.16, 128.56, 101.99, 89.28, 81.30, 79.12, 77.82, 75.92, 68.30, 56.73, 53.29, 52.45, 24.06, 23.29, −0.36; HRMS-ESI (m/z) calculated value C25H26O5SiNa [M+Na]+ 457.1442, measured value 457.1450.
Step 2. the preparation method of compound 16 is the same as that of compound 4, except the following characteristics:
the compound 3 in step 2 of embodiment 2 is replaced by the compound 15 in step 1 of the present embodiment.
The compound 16 is light yellow solid. Yield of the compound 16 is 89%. The yield of compound 16 is calculated as a molar amount of the compound 16 divided by a molar amount of the compound 15×100%.
NMR data and high resolution mass spectrometry data of the compound 16 are as follows.
1H NMR δ=7.29-7.48 (m, 5H), 5.07 (dt, J=2.25, J=2.29, 1H), 3.80 (s, 6H), 3.16 (s, 2H), 3.07 (d, J=2.29 Hz, 2H), 2.55 (d, J=2.25 Hz, 1H), 2.19 (br, 1H); 13C NMR δ=168.89, 132.59, 129.20, 128.40, 121.52, 80.93, 79.33, 77.74, 75.99, 73.78, 72.56, 68.37, 56.67, 53.39, 51.86, 24.10, 23.25; HRMS-ESI (m/z) calculated value C22H18O5Na [M+Na]+ 385.1046, measured value 385.1049.
The present embodiment is to prepare the chain multiyne compound disclosed in the present invention.
The preparation method of compound 17 is the same as that of compound 1, except the following characteristics:
the 1,6-heptadiyne used in embodiment 1 is replaced by propargyl ether with an equal molar amount. The 3-trimethylsilylpropynal in embodiment 1 is replaced by phenyl propargyl aldehyde
(synthesized according to literature Org. Lett. 2012, 14, 4906.) with an equal molar amount.
Yield of compound 17 is 70%. The yield of compound 17 is calculated as a molar amount of the compound 17 divided by a molar amount of propargyl ether×100%.
NMR data and high resolution mass spectrometry data of the compound 17 are as follows.
1H NMR δ=7.43-7.45 (m, 2H), 7.29-7.33 (m, 3H), 5.20 (t, J=1.65 Hz, 1H), 4.33 (d, J=1.65 Hz, 2H), 4.26 (d, J=2.23 Hz 2H), 2.70 (br, 1H), 2.46 (t, J=2.23 Hz, 1H); 13C NMR δ=131.79, 128.72, 128.32, 122.01, 89.93, 88.26, 82.62, 78.85, 77.71, 75.42, 52.12, 56.72, 56.61; HRMS-ESI (m/z) calculated value C15H12O2Na [M+Na]+ 247.0730, measured value 247.0726.
The present embodiment is to prepare the chain multiyne compound disclosed in the present invention.
The preparation method of compound 18 is the same as that of compound 1, except the following characteristics:
the 1,6-heptadiyne used in embodiment 1 is replaced by propargyl ether with an equal molar amount. The 3-trimethylsilylpropynal in embodiment 1 is replaced by p-tolylpropynal
(synthesized according to literature Org. Lett. 2012, 14, 4906.) with an equal molar amount.
Yield of compound 18 is 62%. The yield of compound 18 is calculated as a molar amount of the compound 18 divided by a molar amount of propargyl ether×100%.
NMR data and high resolution mass spectrometry data of the compound 18 are as follows.
1H NMR δ=7.42-7.44 (m, 2H), 7.26-7.30 (m, 2H), 5.21 (t, J=1.66 Hz, 1H), 4.30 (d, J=1.66 Hz, 2H), 4.27 (d, J=2.24 Hz 2H), 2.66 (br, 1H), 2.45 (t, J=2.24 Hz, 1H), 2.35 (s, 3H); 13C NMR δ=131.74, 128.70, 128.29, 122.11, 89.92, 88.29, 82.60, 78.83, 77.73, 75.45, 52.16, 56.73, 56.62, 27.45; HRMS-ESI (m/z) calculated value C16H14O2Na [M+Na]+ 261.0886, measured value 261.0882.
The present embodiment is to prepare the chain multiyne compound disclosed in the present invention.
The preparation method of compound 19 is the same as that of compound 1, except the following characteristics:
the 1,6-heptadiyne used in embodiment 1 is replaced by propargyl ether with an equal molar amount. The 3-trimethylsilylpropynal in embodiment 1 is replaced by 4-phenyl-3-butyn-2-one
(purchased from Alfa Aesar (China) Chemical Co., Ltd., and a trademark number is MFCD0000877) with an equal molar amount.
Yield of compound 19 is 65%. The yield of compound 19 is calculated as a molar amount of the compound 19 divided by a molar amount of propargyl ether×100%.
NMR data and high resolution mass spectrometry data of the compound 19 are as follows.
1H NMR δ=7.44-7.46 (m, 2H), 7.30-7.34 (m, 3H), 4.34 (s, 2H), 4.27 (d, J=2.22 Hz 2H), 2.59 (br, 1H), 2.46 (t, J=2.22 Hz, 1H), 1.87 (s, 3H); 13C NMR δ=131.81, 128.74, 128.31, 122.03, 89.94, 88.27, 82.61, 78.87, 77.70, 75.40, 60.23, 56.74, 56.62, 31.89; HRMS-ESI (m/z) calculated value C16H14O2Na [M+Na]+ 261.0886, measured value 261.0879.
The present embodiment is to prepare the chain multiyne compound disclosed in the present invention.
The preparation method of compound 20 is the same as that of compound 1, except the following characteristics:
the 1,6-heptadiyne used in embodiment 1 is replaced by propargyl ether with an equal molar amount. The 3-trimethylsilylpropynal in embodiment 1 is replaced by 3-pentyn-2-one
(synthesized according to J. Am. Chem. Soc. 2008, 130, 14713.) with an equal molar amount.
Yield of compound 20 is 60%. The yield of compound 20 is calculated as a molar amount of the compound 20 divided by a molar amount of propargyl ether×100%.
NMR data and high resolution mass spectrometry data of the compound 20 are as follows.
1H NMR δ=4.35 (s, 2H), 4.29 (d, J=2.30 Hz 2H), 2.85 (br, 1H), 2.46 (t, J=2.30 Hz, 1H), 1.85 (s, 3H), 1.92 (s, 3H); 13C NMR δ=86.64, 85.27, 82.01, 78.57, 77.50, 75.20, 59.73, 56.62, 56.50, 31.59, 5.4; HRMS-ESI (m/z) calculated value C11H12O2Na [M+Na]+ 199.0730, measured value 199.0727.
The present embodiment is to prepare the chain multiyne compound disclosed in the present invention.
The preparation method of compound 21 is the same as that of compound 1, except the following characteristics:
the 1,6-heptadiyne used in embodiment 1 is replaced by propargyl ether with an equal molar amount. The 3-trimethylsilylpropynal in embodiment 1 is replaced by 1-phenyl-2-butyn-1-one
synthesized according to J. Am. Chem. Soc. 2008, 130, 14713.) with an equal molar amount.
Yield of compound 21 is 60%. The yield of compound 21 is calculated as a molar amount of the compound 21 divided by a molar amount of propargyl ether×100%.
NMR data and high resolution mass spectrometry data of the compound 21 are as follows.
1H NMR δ=7.35-7.31 (m, 2H), 7.11-7.15 (m, 3H), 4.36 (s, 2H), 4.29 (d, J=2.28 Hz 2H), 2.85 (br, 1H), 2.48 (t, J=2.28 Hz, 1H), 1.93 (s, 3H); 13C NMR δ=131.20, 129.34, 127.11, 121.72, 86.82, 85.05, 82.11, 78.93, 77.81, 75.52, 65.71, 56.24, 56.12, 8.29; HRMS-ESI (m/z) calculated value C16H14O2Na [M+Na]+ 261.0886, measured value 261.0878.
The present embodiment is to prepare the chain multiyne compound disclosed in the present invention.
The preparation method of compound 22 is the same as that of compound 1, except the following characteristics:
the 1,6-heptadiyne used in embodiment 1 is replaced by propargyl ether with an equal molar amount. The 3-trimethylsilylpropynal in embodiment 1 is replaced by 4-phenyl-2-butyn-1-al
synthesized according to Angew. Chem., Int. Ed. 2014, 53, 4154.) with an equal molar amount.
Yield of compound 22 is 68%. The yield of compound 22 is calculated as a molar amount of the compound 22 divided by a molar amount of propargyl ether×100%.
NMR data and high resolution mass spectrometry data of the compound 22 are as follows.
1H NMR δ=7.24-7.26 (m, 2H), 7.13-7.22 (m, 3H), 5.14 (br, 1H), 2.65 (br, 1H), 4.30 (d, J=1.57 Hz, 2H), 4.25 (d, J=2.27 Hz, 2H), 2.59 (d, J=2.25 Hz, 1H), 3.25 (d, J=1.60 Hz, 2H); 13C NMR δ=83.85, 80.75, 80.55, 80.13, 78.82, 75.47, 56.85, 56.746, 52.13; HRMS-ESI (m/z) calculated value C16H14O2Na [M+Na]+ 261.0886, measured value 261.0878.
The present embodiment is to prepare the chain multiyne compound disclosed in the present invention.
The preparation method of compound 23 is the same as that of compound 1, except the following characteristics:
the 1,6-heptadiyne used in embodiment 1 is replaced by propargyl ether with an equal molar amount. The 3-trimethylsilylpropynal in embodiment 1 is replaced by cyclohexyl propylaldehyde
synthesized according to Angew. Chem., Int. Ed. 2014, 53, 4154.) with an equal molar amount.
Yield of compound 23 is 71%. The yield of compound 23 is calculated as a molar amount of the compound 23 divided by a molar amount of propargyl ether×100%.
NMR data and high resolution mass spectrometry data of the compound 23 are as follows.
1H NMR δ=5.12 (t, J=1.53 Hz, 1H), 2.75 (br, 1H), 4.33 (d, J=1.53 Hz, 2H), 4.27 (d, J=2.23 Hz, 2H), 2.57 (d, J=2.23 Hz, 1H), 1.75 (m, 4H), 1.56 (m, 6H); 13C NMR δ=87.53, 83.85, 80.83, 80.63, 78.87, 75.67, 56.86, 56.75, 52.76, 33.52, 28.94, 25.63, 25.19; HRMS-ESI (m/z) calculated value C15H18O2Na [M+Na]+ 253.1199, measured value 253.1198.
The present embodiment is to prepare the chain multiyne compound disclosed in the present invention.
The preparation method of compound 24 is the same as that of compound 1, except the following characteristics:
the 1,6-heptadiyne used in embodiment 1 is replaced by propargyl ether with an equal molar amount. The 3-trimethylsilylpropynal in embodiment 1 is replaced by phenyl pentdialkylaldehyde
(synthesized according to J. Org. Chem. 2013, 78, 12018.) with an equal molar amount.
Yield of compound 24 is 54%. The yield of compound 24 is calculated as a molar amount of the compound 24 divided by a molar amount of propargyl ether×100%.
NMR data and high resolution mass spectrometry data of the compound 24 are as follows.
1H NMR δ=7.30-7.48 (m, 5H), 5.17 (t, J=1.69 Hz, 1H), 4.32 (d, J=1.69 Hz, 2H), 4.28 (d, J=2.27 Hz, 2H), 2.60 (d, J=2.27 Hz, 1H), 2.53 (br, 1H); 13C NMR δ=132.48, 129.19, 128.35, 121.32, 81.23, 79.53, 77.64, 75.87, 73.54, 73.15, 72.56, 71.76, 56.85, 56.67, 52.86; HRMS-ESI (m/z) calculated value C17H12O2Na [M+Na]+ 271.0730, measured value 271.0726.
The present embodiment is to prepare the chain multiyne compound disclosed in the present invention.
The preparation method of compound 25 is the same as that of compound 3, except the following characteristics:
the 2,2-dimethyl dipropargylmalonate used in step 1 of embodiment 2 is replaced by dimethyl 2-propargyl-2-(5-phenyl-2,4-pentadiynyl) malonate (synthesized according to literature J. Am. Chem. Soc. 2008, 130, 14713.) with an equal molar amount. The 3-trimethylsilylpropynal is replaced by 3-pentyn-2-one
(synthesized according to literature J. Am. Chem. Soc. 2007, 129, 3826.) with an equal molar amount.
Yield of compound 25 is 50%. The yield of compound 25 is calculated as a molar amount of the compound 25 divided by a molar amount of 2,2-dimethyl dipropargylmalonate×100%.
NMR data and high resolution mass spectrometry data of the compound 25 are as follows.
1H NMR δ=7.30-7.48 (m, 5H), 3.77 (s, 6H), 3.15 (s, 2H), 3.09 (s, 2H), 2.65 (br, 1H), 1.75 (s, 3H), 1.80 (s, 3H); 13C NMR δ=168.87, 132.55, 129.16, 128.35, 121.42, 80.90, 79.31, 77.69, 75.87, 73.43, 72.24, 56.66, 53.35, 51.92, 31.58, 24.20, 23.31, 10.67; HRMS-ESI (m/z) calculated value C24H22O5Na [M+Na]+ 413.1359, measured value 413.1358.
The present embodiment is to describe an application of the chain multiyne compound disclosed in the present invention in synthesizing the fused-ring metallacyclic compound.
Wherein, DCM is dichloromethane. OsCl2(PPh3)3 (500 mg, 0.48 mmol, synthesized according to literature Inorg. Synth., 1989, 26, 184.) and PPh3 (629 mg, 2.40 mmol, purchased from Sinopharm Chemical Reagent Co., Ltd., a trademark number is 80136926) were dissolved into 20 mL dichloromethane under an atmosphere of N2 and magnetic stirring.
A dichloromethane (dissolving 0.72 mmol HC≡CCH(OH)C≡C(CH2)3C≡CH into 2 mL dichloromethane solution) solution of HC≡CCH(OH)C≡(CH2)C≡CH (105 mg, 0.72 mmol, the synthesis of this compound, refer to embodiment 1) was added gradually.
The solution reacted for 1.5 h at room temperature and a color of the solution was changed from green to red and a reaction mixture was obtained.
The obtained reaction mixture was concentrated under vacuum to 2 mL.
The concentrated mixture was washed with Et2O (diethyl ether) for 3 times, with 30 mL of diethyl ether at each time.
450 mg of red solid Os-1 was obtained, and yield is 80%. The yield of Os-1 is calculated as a molar amount of the Os-1 divided by a molar amount of OsCl2(PPh3)3×100%.
NMR data and high resolution mass spectrometry data of the Os-1 are as follows.
1H-NMR (300.1 MHz, CD2Cl2): δ=13.33 (s, 1H, C7H), 7.61 (s, 1H, C3H), 7.02-7.79 (m, 45H, Ph), 2.44. (dt, J(HH)=7.27 Hz, J(HH)=3.63 Hz, 2H, C10H), 2.01 (tt, apparent quint, J(HH)=7.27 Hz, 2H, C9H), 1.79 (t, J(HH)=7.27 Hz, 2H, C8H); 31P{1H} NMR (121.5 MHz, CD2Cl2): δ=5.76 (t, J(PP)=5.72 Hz, CPPh3), 3.23 (d, J(PP)=5.72 Hz, OsPPh3); 13C{1H} NMR (75.5 MHz, CD2Cl2, plus 13C-dept 135, 1H-13C HSQC and 1H-13C HMBC): δ 321.56 (dt, apparent q, J(PC)=13.33 Hz, J(PC)=13.33 Hz, C1), 216.58 (t, J(PC)=10.59 Hz, C7), 180.44 (s, C5), 175.50 (t, J(PC)=3.53 Hz, C6), 172.04 (dt, J(PC)=23.30 Hz, J(PC)=3.21 Hz, C4), 147.96 (dt, J(PC)=15.36 Hz, J(PC)=2.77 Hz, C3), 128.00-135.48 (Ph), 125.89 (dt, J(PC)=95.84 Hz, J(PC)=3.61 Hz, C2), 120.56 (d, J(PC)=90.83 Hz, Ph), 31.32 (s, C8), 29.57 (s, C10), 29.28 (s, C9). HRMS (ESI): m/z calculated value [C64H53ClP3Os]+, 1141.2658; measured value, 1141.2646.
The present embodiment is to describe an application of the chain multiyne compound disclosed in the present invention in synthesizing the fused-ring metallacyclic compound (osmapentalyne Os-2).
A preparation method of Os-2 is the same as that of Os-1 of embodiment 18, except the following characteristics:
the HC≡CCH(OH)C≡C(CH2)3C≡CH used in embodiment 18 is replaced by HC≡CCH(OH)C≡CCH2OCH2C≡CH (the preparation method of this compound refers to embodiment 3) with an equal molar amount.
Red solid Os-2 is obtained, and its yield is 82%. The yield of Os-2 is calculated as a molar amount of the Os-2 divided by a molar amount of OsCl2(PPh3)3×100%.
NMR data and high resolution mass spectrometry data of the Os-2 are as follows.
1H-NMR (300.1 MHz, CD2Cl2): δ=13.27 (s, 1H, C7H), 7.69 (s, 1H, C3H), 7.01-7.79 (Ph 46H, Ph and above-mentioned C3H), 4.55 (s, C9H), 3.89 (s, C8H); 31P{1H} NMR (121.5 MHz, CD2Cl2): δ=6.05 (t, J(PP)=4.67 Hz, CPPh3), 2.49 (d, J(PP)=4.67 Hz, OsPPh3); 13C{1H} NMR (75.5 MHz, CD2Cl2, plus 13C-dept 135, 1H-13C HSQC and 1H-13C HMBC): δ 302.51 (dt, apparent q, J(PC)=13.54 Hz, J(PC)=13.54 Hz, C1), 211.53 (t, J(PC)=11.06 Hz, C7), 172.79 (s, C5), 171.55 (t, J(PC)=4.96 Hz, C6), 169.26 (dt, J(PC)=23.95 Hz, J(PC)=2.97 Hz, C4), 150.34 (d, J(PC)=15.37 Hz, C3), 120.27-135.82 (Ph), 119.81 (d, J(PC)=90.43 Hz, C2), 71.39 (s, C8), 69.17 (s, C9); HRMS (ESI): m/z calculated value [C63H51ClOP3Os]+, 1143.2451; measured value, 1143.2435.
The present embodiment is to describe an application of the chain multiyne compound disclosed in the present invention in synthesizing the fused-ring metallacyclic compound (osmapentalyne Os-3).
A preparation method of Os-3 is the same as that of Os-1 of embodiment 18, except the following characteristics:
the HC≡CCH(OH)C≡C(CH2)3C≡CH used in embodiment 18 is replaced by HC≡CCH(OH)C≡CCH2C(COOMe)2CH2C≡CH (the preparation method of this compound refers to embodiment 2) with an equal molar amount.
Red solid Os-3 is obtained, and its yield is 85%. The yield of Os-3 is calculated as a molar amount of the Os-3 divided by a molar amount of OsCl2(PPh3)3×100%.
NMR data and high resolution mass spectrometry data of the Os-3 are as follows.
1H-NMR (500.2 MHz, CD2Cl2): δ=13.16 (s, 1H, C7H), 7.67 (s, 1H, C3H), 7.02-7.80 (m, 46H, Ph and above-mentioned C3H), 3.64 (s, 6H, COOCH3), 3.12 (s, C10H), 2.44 (s, C8H); 31P{1H} NMR (202.5 MHz, CD2Cl2): δ=5.79 (t, J(P,P)=5.00 Hz, CPPh3), 3.31 (d, J(P,P)=5.00 Hz, OsPPh3); 13C{1H} NMR (125.8 MHz, CD2Cl2, plus 13C-dept 135, 1H-13C HSQC and 1H-13C HMBC): δ 321.57 (dt, apparent q, J(PC)=13.33 Hz, J(PC)=13.33 Hz, C1), 217.23 (q, J(P,C)=9.78 Hz, J(P,C)=19.55 Hz, C7), 173.07 (s, C5), 172.16 (s, COOCH3), 171.81 (d, J(P,C)=23.02 Hz, C4), 170.12 (s, C6), 149.22 (d, J(P,C)=16.31 Hz, C3), 128.18-135.61 (Ph), 128.15 (dt, J(P,C)=81.30 Hz, J(PC)=3.64 Hz, C2), 120.30 (d, J(PC)=91.07 Hz, Ph), 64.38 (s, C9), 53.54 (s, COOCH3), 39.07 (s, C8), 37.62 (s, C10); HRMS (ESI): m/z calculated value [C68H57ClO4P3Os]+, 1257.2768; measured value, 1257.2771.
The present embodiment is to describe an application of the chain multiyne compound disclosed in the present invention in synthesizing the fused-ring metallacyclic compound (ru-pentalyne Ru-1).
A preparation method of Ru-1 is the same as that of Os-1 of embodiment 18, except the following characteristics:
the HC≡CCH(OH)C≡C(CH2)3C≡CH used in embodiment 18 is replaced by HC≡CCH(OH)C≡CCH2C(COOMe)2CH2C≡CH (the preparation method of this compound refers to embodiment 2) with an equal molar amount.
Red solid Ru-1 is obtained, and its yield is 70%. The yield of Ru-1 is calculated as a molar amount of the Ru-1 divided by a molar amount of RuCl2(PPh3)3×100%.
NMR data and high resolution mass spectrometry data of the Ru-1 are as follows.
1H NMR (300.1 MHz, CD2Cl2): δ=13.06 (s, 1H, C7H), 7.33 (1H, C3H, obtained by HSQC), 6.99-7.81 (46H, Ph and above-mentioned C3H), 3.64 (s, 6H, COOCH3), 2.96 (t, J(H,H)=3.63, C10H), 2.76 (s, C8H); 31P{1H} NMR (121.5 MHz, CD2Cl2): δ=29.59 (d, J(P,P)=5.89 Hz, RuPPh3), 6.38 (t, J(P,P)=5.89 Hz, CPPh3); 13C{1H} NMR (75.5 MHz, CD2Cl2, plus 13C-dept 135, 1H-13C HSQC and 1H-13C HMBC): δ=356.95 (br, C1), 251.89 (t, J(P,C)=11.96, C7), 190.23 (dt, J(P,C)=25.65 Hz, J(P,C)=4.90 Hz, C4), 180.98 (d, J(P,C)=1.97 Hz, C5), 171.77 (s, COOCH3), 164.57 (t, J(P,C)=4.24 Hz, C6), 154.99 (dt, J(P,C)=14.44 Hz, J(P,C)=3.07 Hz, C3), 128.18-135.76 (other aromatic carbons), 122.86 (dt, J(P,C)=92.99 Hz, J(P,C)=4.02 Hz, C2), 119.57 (other aromatic carbons), 64.14 (s, C9), 53.63 (s, COOCH3, obtained by 13C-dept 135), 39.06 (s, C8), 37.35 (s, C10); HRMS (ESI): m/z calculated value [C68H57ClO4P3Ru]+, 1167.2212; measured value, 1167.2215.
The present embodiment is to describe an application of the chain multiyne compound disclosed in the present invention in synthesizing the fused-ring metallacyclic compound (rhodium double five-membered ring compound Rh-1).
A preparation method of Ru-2 is the same as that of Os-1 of embodiment 18, except the following characteristics:
the HC≡CCH(OH)C≡C(CH2)3C≡CH used in embodiment 18 is replaced by HC≡CCH(OH)C≡CCH2C(COOMe)2CH2C≡CH (the preparation method of this compound refers to embodiment 2) with an equal molar amount. The OsCl2(PPh3)3 is simultaneously replaced by RhCl(PPh3)3.
Yellow solid Ru-2 is obtained, and its yield is 91%. The yield of Ru-2 is calculated as a molar amount of the Ru-2 divided by a molar amount of RhCl(PPh3)3×100%.
NMR data and high resolution mass spectrometry data of the Ru-2 are as follows.
1H-NMR (600.1 MHz, CD2Cl2): δ=10.27 (d, J(PH)=29.75 Hz, 1H, C1H), 6.87-8.20 (45H, Ph), 6.53 (s, 1H, C7H), 3.57 (s, 3H, COOCH3), 3.54 (s, 3H, COOCH3), 3.45 (d, J(HH)=8.95 Hz, 1H, C3H), 2.35 (d, J(HH)=16.47 Hz, 1H, C10H), 2.27 (d, J(HH)=16.47 Hz, 1H, C10H), 2.01 (d, J(HH)=17.02 Hz, 1H, C8H), 1.78 (d, J(HH)=17.02 Hz, 1H, C8H), 0.17 (d, J(HH)=8.95 Hz, 1H, OH); 31P{1H} NMR (242.9 MHz, CD2Cl2): δ=33.33 (ddd, J(PP)=431.55 Hz, J(RhP)=126.88 Hz, J(PP)=5.74 Hz, RhPPh3), δ=31.04 (ddd, J(PP)=431.55 Hz, J(RhP)=126.88 Hz, J(PP)=5.74 Hz, RhPPh3), 8.00 (br, CPPh3); 13C{1H} NMR (150.5 MHz, CD2Cl2, plus 13C-dept 135, 1H-13C HSQC and 1H-13C HMBC): δ=221.27 (br, C1), 174.08 (s, COOCH3), 173.27 (s, COOCH3), 167.45 (br, C4), 154.85 (s, C6), 153.49 (br, C7), 145.57 (s, C5), 127.32-136.42 (Ph), 122.91 (d, J(PC)=46.59 Hz, C2), 122.89 (d, J(PC)=84.89 Hz, Ph), 80.32 (d, J(PC)=25.69 Hz, C3), 64.39 (s, C9), 52.90 (s, COOCH3), 52.70 (s, COOCH3), 39.06 (s, C10), 36.01 (s, C10); HRMS (ESI): m/z calculated value [C68H60ClO5P3Rh]+, 1187.2392 [M+H]+; measured value, 1187.2418.
The present embodiment is to describe an application of the chain multiyne compound disclosed in the present invention in synthesizing the fused-ring metallacyclic compound (Ir-pentalene Ir-1).
A preparation method of Ir-1 is the same as that of Os-1 of embodiment 18, except the following characteristics:
the OsCl2(PPh3)3 used in embodiment 18 is replaced by IrHCl2(PPh3)3 (the preparation method of this compound refers to embodiment 1).
Yield of Ir-1 is 35%. The yield of Ru-2 is calculated as a molar amount of the Ir-1 divided by a molar amount of IrHCl2(PPh3)3×100%.
NMR data and high resolution mass spectrometry data of the Ir-1 are as follows.
1H-NMR (600.1 MHz, CDCl3): δ=14.34 (s, 1H, C7H), 12.66 (d, J(PH)=20.03 Hz, 1H, C1H), 8.67 (t, J(PH)=2.35 Hz, 1H, C3H), 6.98-7.90 (m, 45H, Ph), 2.56 (m, 2H, C10H), 1.64 (tt, apparent quint, J(HH)=7.44 Hz, 2H, C9H), 1.15 (t, J(HH)=7.44 Hz, 2H, C8H); 31P{1H} NMR (242.9 MHz, CDCl3): δ=10.91 (t, J(PP)=5.97 Hz, CPPh3), −5.77 (d, J(PP)=5.97 Hz, IrPPh3); 13C{1H} NMR (150.9 MHz, CDCl3, plus 13C-dept 135, 1H-13C HSQC and 1H-13C HMBC): δ=230.16 (br, C7), 215.13 (br, C1), 186.44 (s, C5), 184.96 (s, C6), 169.34 (dt, J(PC)=22.59 Hz, J(PC)=2.90 Hz, C4), 151.98 (d, J(PC)=24.44 Hz, C3), 137.51 (dt, J(PC)=62.94 Hz, J(PC)=3.21 Hz, C2), 119.36-135.16 (Ph), 31.75 (s, C8), 31.00 (s, C10), 28.75 (s, C9); HRMS (ESI): m/z calculated value [C64H54ClP3Ir]+, 143.2748; measured value, 1143.2739.
The present embodiment is to describe an application of the chain multiyne compound disclosed in the present invention in synthesizing the fused-ring metallacyclic compound (osmapentalene Os-4).
A preparation method of Os-4 is the same as that of Os-1 of embodiment 18, except the following characteristics:
the HC≡CCH(OH)C≡C(CH2)3C≡CH used in embodiment 18 is replaced by HC≡CCH(OH)C≡CCH2OCH2CH═C═CH (the preparation method of this compound refers to embodiment 7) with an equal molar amount.
Red solid Os-4 is obtained. Yield of Os-4 is 80%. The yield of Os-4 is calculated as a molar amount of the Os-4 divided by a molar amount of OsCl2(PPh3)3×100%.
NMR data and high resolution mass spectrometry data of the Os-4 are as follows.
1H-NMR (500.2 MHz, CD2Cl2): δ=14.01 (d, J(P,H)=17.17 Hz, 1H, C1H), 8.21 (s, 1H, C3H), 6.90-7.81 (m, 45H, Ph), 4.12 (s, 2H, C9H), 3.21 (s, 2H, C10H), 3.03 (s, 2H, C8H); 31P{1H} NMR (202.5 MHz, CD2Cl2): δ=11.81 (d, J(P,P)=4.95 Hz, CPPh3), −13.19 (d, J(PP)=4.95 Hz, OsPPh3); 13C{1H} NMR (125.8 MHz, CD2Cl2, plus 13C-dept 135, 1H-13C HSQC and 1H-13C HMBC): δ=339.19 (br, C1), 226.16 (t, J(P,C)=4.37 Hz, C7), 183.46 (s, C5), 176.00 (d, J(PC)=25.20 Hz, C4), 163.13 (s, C6), 145.12 (d, J(P,C)=21.87 Hz, C3), 134.66 (dt, J(P,C)=70.73 Hz, J(P,C)=3.92 Hz, C2), 118.46-134.17 (Ph), 69.92 (s, C10), 65.41 (s, C9), 23.08 (s, C8); HRMS (ESI): m/z calculated value [C64H53ClOP3Os]+, 1157.2607; measured value, 1157.2594.
The present embodiment is to describe an application of the chain multiyne compound disclosed in the present invention in synthesizing the fused-ring metallacyclic compound (osmapentalene Os-5).
A preparation method of Os-5 is the same as that of Os-1 of embodiment 18, except the following characteristics:
the HC≡CCH(OH)C≡C(CH2)3C≡CH used in embodiment 18 is replaced by PhC≡CCMe(OH)C≡CCH2OCH2C≡CH (the preparation method of this compound is the same as compound 5) with an equal molar amount.
Red solid Os-5 is obtained. Yield of Os-5 is 43%. The yield of Os-5 is calculated as a molar amount of the Os-5 divided by a molar amount of OsCl2(PPh3)3×100%.
NMR data and high resolution mass spectrometry data of the Os-5 are as follows.
1H-NMR (300.1 MHz, CD2Cl2): δ=7.05-7.72 (m, 50H, Ph), 4.45 (s, C1H), 3.78 (s, C8H), 2.25 (s, CH3); 31P{1H} NMR (121.5 MHz, CD2Cl2): δ=14.01 (t, J(PP)=4.72 Hz, CPPh3), 6.86 (d, J(PP)=4.72 Hz, OsPPh3); 13C{1H} NMR (75.5 MHz, CD2Cl2, plus 13C-dept 135, 1H-13C HSQC and 1H-13C HMBC): δ 330.11 (br, C7), 225.2 (br, C1), 171.79 (s, C5), 171.34 (t, J(PC)=4.94 Hz, C6), 168.11 (dt, J(PC)=23.45 Hz, J(PC)=2.85 Hz, C4), 148.33 (d, J(PC)=15.37 Hz, C3), 120.25-135.76 (Ph), 118.11 (d, J(PC)=90.21 Hz, C2), 71.35 (s, C8), 69.05 (s, C9), 25.12 (s, CH3); HRMS (ESI): m/z calculated value [C70H57ClOP3Os]+, 1233.2920; measured value, 1233.2917.
The preferred embodiments of the present invention are described in detail above. However, the present invention is not limited to the specific details of the above embodiments. Various simple modifications made to the technical solutions of the present invention within the scope of the technical concept of the present invention all belong to the protection scope of the present invention.
Additionally, any combination of various embodiments of the present invention may also be performed as long as it does not violate the spirit of the present invention, and should also be regarded as a disclosure of the present invention.
| Number | Date | Country | Kind |
|---|---|---|---|
| 201510241958.4 | May 2015 | CN | national |
| 201510606889.2 | Sep 2015 | CN | national |
| Number | Date | Country | |
|---|---|---|---|
| Parent | PCT/CN2016/081392 | May 2016 | US |
| Child | 15811277 | US |
